Referencias correspondientes a la pieza ARD 356

1. Aguilera Zepeda JM, et al. Estudio prospectivo, comparativo, ciego, aleatorizado, con grupos paralelos para evaluar la efectividad de una combinación de glucosamina sulfato y meloxicam en Osteoartritis de cadera y rodilla. Actualizaciones en Reumatología. Inst Nac Rehab. México DF, Mayo 2008:1-22.
2. Gouze JN, et al. Interleukin-1beta down-regulates the expression of glucuronosyltransferase I, a key enzyme priming glycosaminoglycan biosynthesis: in uence of glucosamine on interleukin-1beta-mediated effects in rat chondrocytes. Arthritis Rheum. 2001 Feb;44(2):351-60.
3. Yocum D, et al. Safety and ef cacy of meloxicam in the treatment of osteoarthritis: a 12-week, double-blind, multiple-dose, placebo-controlled trial. The Meloxicam Osteoarthritis Investigators. Arch Intern Med. 2000 Oct 23;160(19):2947-54.
4. Reginster JY, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001 Jan 27;357(9252):251-6.Wilson C, O’Mahony B, Farrell T, Friend B, Taylor D .Modern Tablet Film Coatings and In uence on Ease of Swallowing. American Association of Pharmaceutical Scientists Meeting, 2003.
5. Reginster JY, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebo-controlled clinical trial. Lancet. 2001 Jan 27;357(9252):251-6.
6. Pavelká K, et al. Glucosamine sulfate use and delay of progression of knee osteoarthritis: a 3-year, randomized, placebo-controlled, double-blind study. Arch Intern Med. 2002 Oct 14;162(18):2113-23.
7. Herrero-Beaumont G, et al. Glucosamine sulfate in the treatment of knee osteoarthritis symptoms: a randomized, double-blind, placebo-controlled study using acetaminophen as a side comparator. Arthritis Rheum. 2007 Feb;56(2):555-67.
8. Towheed TE, et al. Glucosamine therapy for treating osteoarthritis. Cochrane Database Syst Rev. 2001;(1):CD002946.
9. Das A Jr, et al. Ef cacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis. Osteoarthritis Cartilage. 2000 Sep;8(5):343-50.
10. Lef er CT, et al. Glucosamine, chondroitin, and manganese ascorbate for degenerative joint disease of the knee or low back: a randomized, double-blind, placebo-controlled pilot study. Mil Med. 1999 Feb;164(2):85-91.
11. Fidia Farmaceutici S.P.A. Data on file.
12. Prospecto autorizado del producto Hyalone. Laboratorios Bagó 2016.
13. Migliore A, et al. Intra-articular injection of hyaluronic acid (MW 1,500-2,000 kDa; HyalOne) in symptomatic osteoarthritis of the hip: a prospective cohort study.Arch Orthop Trauma Surg. 2011 Dec;131(12):1677-85.
14. Angelo Vetro, et al. Effects of single high molecular weight sodium hyaluronate injection in osteoarthritis of knee. ISIAT (Internat. Sympos. Intra-Artic. Treat.) Barcelona 3/5 October 2013.
15. Migliore A, et al. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther. 2009;11(6):R183.
    17 . Singh K, Sharma R and Rai J. Diacerein as adjuvant to diclofenac sodium in osteoarthritis knee. International Journal of Rheumatic Diseases 2012; 15: 69–77.
16. Toegel S, et. al. Comparison between chondroprotective effects of glucosamine, curcumin, and diacerein in IL-1beta-stimulated C-28/I2 chondrocytes. Osteoarthritis Cartilage. 2008 Oct;16(10):1205-12.
17. Yaron M, Shirazi I, Yaron I. Anti-interleukin-1 effects of diacerein and rhein in human osteoarthritic synovial tissue and cartilage cultures. Osteoarthritis Cartilage. 1999 May;7(3):272-80.
18. Dougados M, et. al. Evaluation of the structure-modifying effects of diacerein in hip osteoarthritis: ECHODIAH, a three-year, placebo-controlled trial. Evaluation of the Chondromodulating Effect of Diacerein in OA of the Hip. Arthritis Rheum. 2001 Nov;44(11):2539-47.